Home/Filings/4/0001415889-19-000320
4//SEC Filing

SNODGRASS H. RALPH 4

Accession 0001415889-19-000320

CIK 0001411685other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 5:12 PM ET

Size

6.7 KB

Accession

0001415889-19-000320

Insider Transaction Report

Form 4
Period: 2019-03-13
SNODGRASS H. RALPH
DirectorPRES./CHIEF SCIENTIFIC OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2019-03-13$1.50/sh+2,500$3,75062,724 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2019-03-132,5000 total
    Exercise: $1.50From: 2013-03-24Exp: 2019-03-24Common Stock (2,500 underlying)

Issuer

VistaGen Therapeutics, Inc.

CIK 0001411685

Entity typeother

Related Parties

1
  • filerCIK 0001415876

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:12 PM ET
Size
6.7 KB